

























![]()
Q1: 2026-05-07 Earnings Summary
EPS of $1.63 misses by $0.17
|
Revenue of
$51.72M
(14.09% Y/Y)
misses by $7.14M
Ligand Pharmaceuticals Incorporated (LGND) Q1 2026 Earnings Call May 7, 2026 8:30 AM EDT
Company Participants
Melanie Herman - Executive Director of Investor Relations and Financial Planning & Analysis
Todd Davis - CEO & Director
Octavio Espinoza - Chief Financial Officer
Lauren Hay - Vice President of Strategic Planning & Investment Analytics
Michael Vigilante
Conference Call Participants
Matthew Hewitt - Craig-Hallum Capital Group LLC, Research Division
Annabel Samimy - Stifel, Nicolaus & Company, Incorporated, Research Division
Joohwan Kim - Citigroup Inc., Research Division
Sahil Dhingra - RBC Capital Markets, Research Division
Joe Pantginis
John Vandermosten - Zacks Investment Research, Inc.
Presentation
Operator
Hello, everyone. Thank you for joining us, and welcome to Ligand's First Quarter 2026 Earnings Call. [Operator Instructions] I will now hand the conference over to Melanie Herman, head of [Technical Difficulty]. Please go ahead.
Melanie Herman
Executive Director of Investor Relations and Financial Planning & Analysis
Good morning, everyone, and welcome to Ligand's First Quarter 2026 Earnings Call. With me on the call today are CEO, Todd Davis; Chief Financial Officer, Octavio Espinoza, Vice President of Portfolio Strategy and Investments, Lauren Hay; and Vice President of Investments and Business Development, Michael Vigilante.
During the call today, we will review the financial results released earlier today and provide commentary on our partner portfolio and business development activities, followed by a question-and-answer session.
Before we get started, I would like to point out that we will be discussing non-GAAP results, which exclude certain items such as stock-based compensation, amortization of intangible assets, amortization or impairment of financial assets and gains or losses from derivative assets, amongst others. I encourage you to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP measures, which can be found in today's release available on our website. We believe these adjusted measures provide valuable insight into our core operating performance, both historically and moving forward. Our earnings
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。